Clinical trials
Leukemia trials in Germany with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2017 | 1 |
| 2020 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| European Working Group of MDS in Childhood | 2 |
| Antisoma Research | 1 |
| Centre for Research and Technology Hellas | 1 |
| Charite University, Berlin, Germany | 1 |
| Dutch Childhood Oncology Group | 1 |
| Facet Biotech | 1 |
| German CML Study Group | 1 |
| Glycostem Therapeutics BV | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 22 |
| Leukemia, Myeloid, Acute | 5 |
| Myelodysplastic Syndromes | 4 |
| Hematologic Neoplasms | 3 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3 |
| Leukemia, Myelomonocytic, Chronic | 3 |
| Lymphoma | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Anemia, Refractory | 2 |
| Anemia, Refractory, with Excess of Blasts | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.